Real-time ESG Scores

Amgen Inc

Amgen Inc is part of the Pharmaceuticals, Biotechnology & Life Sciences sector. The company has a ESG Pulse of 0.84 which is calculated using alternative data outside of company disclosure to provide an 'outside-in' view on company ESG performance.

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, a pegylated protein to treat cancer patients; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Sensipar/Mimpara to treat secondary hyperparathyroidism; and EPOGEN to treat anemia caused by chronic kidney disease. It also markets other products in various markets, including Nplate, Vectibix, Repatha, Parsabiv, BLINCYTO, Aimovig, NEUPOGEN, Otezla, AMGEVITA, KANJINTI, EVENITY, IMLYGIC, MVASI, and Corlanor. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with Novartis; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; QIAGEN N.V.; and Adaptive Biotechnologies. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.

ESG Pulse

ESG Pulse is ranked on a scale of -1 (negative) to +1 (good). This is the average sentiment of all items that have been classified as material ESG'
Updated on:
2022-04-12

Historical ESG Pulse

View historical company ESG pulse and compare against industry, overlay stock prices or view vs peers.

Materiality

View company ESG performance broken down by the 26 SASB topics.

Traditional ESG data doesn't give you the full picture

Old style esg data
The old way
Reliant on company disclosure and analysts
Traditional providers such as MSCI and Sustainalytics rely on company disclosure - which happens infrequently. They employ armies of analysts to gather this data.
  • ESG data and scores are stale (every 6-12 months)
  • Low amount company coverage
  • ESG data is extremely expensive
  • ESG data is not always transparent/objective
Real time esg score in chart
The new way
Dynamic, real-time ESG data
Alternative data such as news, media, job postings, social media and others - allow us to extract signals from the 'outside-in' using AI and fully automated approaches.
  • A check mark
    Real-time ESG data
  • A check mark
    Unlimited coverage of public/private companies
  • A check mark
    Affordable software for analysis
  • A check mark
    Explainable, transparent ESG
Get access to all the data